Syrebo

Syrebo (brand name of Shanghai Siyi Intelligent Technology) has established itself as a domestic leader in soft rehabilitation robotics since its founding in 2017. The company’s pneumatic-driven soft exoskeleton technology addresses hand function recovery for stroke patients, with products now serving over 3,000 medical institutions across more than 80 countries and regions.

Company Overview

Founded in September 2017 by Yin Ganggang, a mechanical engineering graduate from Jilin University with prior experience at Sany Heavy Industry, Syrebo operates with dual headquarters in Shanghai (International Medical Park) and Chengdu. The company holds National High-Tech Enterprise certification and has participated in formulating the industry standard “Electromagnetic Compatibility Requirements and Test Methods for Rehabilitation Training Robots.”

The founding team draws expertise from Jilin University, Harbin Institute of Technology, Shanghai Jiao Tong University, and University of Electronic Science and Technology of China, with core members possessing over ten years of experience in robotics and rehabilitation medicine.

Core Products

Syrebo Hand Rehabilitation Robot Gloves

The flagship product line includes multiple models (E10, C10, C11, C12, 08E, SY-HRE12, SY-HRC15) designed for different clinical and home use scenarios. These soft pneumatic exoskeleton gloves combine flexible robotics technology with neuroscience principles, offering:

• Passive flexion/extension training
• Mirror therapy for bilateral coordination
• Task-oriented training
• Active game-based rehabilitation
• Single finger training capabilities

The gloves accommodate patients with muscle strength levels 0-5 and have obtained FDA registration (2021), CE marking, NMPA approval, and ISO 13485 certification.

EasyWalk Soft Lower Limb Exoskeleton

Launched as China’s first soft lower limb exoskeleton, EasyWalk combines bionic structural design with AI control algorithms. Key specifications include:

• Weight under 3 kg (concentrated at waist)
• Bowden cable power transmission
• No rigid frame design
• Real-time force control
• Voice-activated emergency stop (patented)

The product targets stroke patients, spinal cord injury patients, and elderly individuals requiring gait assistance.

Dynamic Arm Support (SYUH01)

An upper limb rehabilitation device designed for neurological disorder patients, featuring lightweight materials and human factors engineering to minimize gravity effects during arm movement. It can pair with hand rehabilitation gloves for full upper extremity therapy.

Technology & Innovation

Syrebo’s core technological advantages include:

Soft Robotics Platform: Pneumatic artificial muscles drive finger joints without rigid frames, providing comfortable and safe rehabilitation training.

Brain-Computer Interface Integration: The company explores BCI technology to capture brain signals, stimulate active patient intention, and activate motor circuits for neural pathway reconstruction. The BCI-enabled hand rehabilitation robot received CMEF’s “Top 10 Innovative Technology Products” award in 2022.

AI-Assisted Rehabilitation: Cloud-based platforms enable remote prescription by therapists, real-time training data monitoring, and adaptive rehabilitation protocol adjustments.

The company holds over 30 authorized patents with nearly 100 patent applications filed, including more than 10 invention patents.

Market Presence

Syrebo’s products have achieved significant commercial traction:

• 80+ countries and regions served
• 3,000+ clinics and medical institutions
• Multi-scenario coverage: hospitals, communities, and home use

Key clinical partners include Huashan Hospital (Fudan University), West China Hospital (Sichuan University), Shanghai Jiao Tong University, Shanghai University of Traditional Chinese Medicine, Tohoku University (Japan), and Royal Buckinghamshire Hospital (UK).

The company positions its products as “medical-standard consumer-grade rehabilitation robots,” addressing the shortage of rehabilitation therapists in China (approximately 30x gap compared to developed countries) by enabling one therapist to supervise multiple patients simultaneously.

Key Milestones

• 2017: Company founded in Shanghai
• 2020: Began international market expansion
• 2021: Obtained FDA certification; completed Pre-A round funding (Daoyuan Capital)
• 2022: EasyWalk soft exoskeleton launched; participated in industry standard formulation; received CMEF innovation award
• 2023: Completed Series A funding (~CNY 100M, led by Guosheng Capital)

Frequently Asked Questions

What conditions can Syrebo gloves treat?

Syrebo hand rehabilitation gloves are designed for hand dysfunction caused by stroke, cerebral hemorrhage, cerebral infarction, incomplete spinal cord injury, traumatic brain injury, hemiplegia, multiple sclerosis, and pediatric developmental delays.

Does Syrebo have FDA and CE certification?

Yes, Syrebo’s hand rehabilitation glove series has received FDA registration (2021), CE marking, NMPA approval, and ISO 13485 certification, enabling sales in North America, Europe, and China.

Can Syrebo products be used at home?

Yes, Syrebo offers both professional hospital-grade devices and consumer-grade products specifically designed for home and community rehabilitation. The home-use versions connect to cloud platforms allowing therapists to remotely monitor training progress and adjust protocols.